Alignment Healthcare, Inc. (ALHC) shareholders
Close on Nov 18, 2026Market cap $1.41BP/E 61.1Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| General Atlantic Partners 95, L.P. Joint filing with General Atlantic, L.P. (22.20%), GAPCO GmbH & Co. KG (22.20%) and 8 more | 43,993,323 | 22.20% | 13G (passive) amendment | Jun 30, 2025 |
| General Atlantic (SPV) GP, LLC Joint filing with General Atlantic, L.P. (12.30%), General Atlantic Partners 95, L.P. (12.30%) and 8 more | 24,287,227 | 12.30% | 13G (passive) amendment | Sep 17, 2025 |
| BlackRock, Inc. | 23,530,373 | 11.30% | 13G (passive) amendment | Sep 30, 2026 |
| Wellington Investment Advisors Holdings LLP Joint filing with Wellington Management Group LLP (8.40%), Wellington Group Holdings LLP (8.40%) and 1 more | 17,098,936 | 8.40% | 13G (passive) amendment | Mar 31, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (7.70%) | 14,792,082 | 7.70% | 13G (passive) | Dec 31, 2025 |
| Wellington Group Holdings LLP Joint filing with Wellington Management Group LLP (7.30%), Wellington Investment Advisors Holdings LLP (7.30%) and 1 more | 14,070,893 | 7.30% | 13G (passive) amendment | Dec 31, 2025 |
| Q Healthcare Holding LLC Joint filing with Qatar Investment Authority (6.69%) | 13,246,096 | 6.69% | 13G (passive) | Sep 17, 2025 |
| GAPCO Management GmbH Joint filing with General Atlantic, L.P. (6.60%), General Atlantic Partners 95, L.P. (6.60%) and 8 more | 13,167,733 | 6.60% | 13G (passive) amendment | Dec 31, 2025 |
| T. Rowe Price Investment Management, Inc. | 12,331,720 | 6.20% | 13G (passive) | Jun 30, 2025 |
| Vanguard Portfolio Management | 11,874,585 | 5.74% | 13G (passive) | Jun 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ALHC | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 19,342,956 | 9.24% | $460.56M | +5,267,759 | 0.01% |
| Wellington Management Group Llp | 18,780,363 | 8.97% | $447.16M | +1,681,427 | 0.08% |
| FMR LLC | 13,924,329 | 6.65% | $331.54M | −1,967,735 | 0.01% |
| T. Rowe Price Investment Management, Inc. | 13,119,557 | 6.27% | $312.38M | −28,099 | 0.20% |
| Vanguard Portfolio Management LLC | 11,672,259 | 5.58% | $277.92M | +1,962,188 | 0.01% |
| Invesco Ltd. | 10,365,640 | 4.95% | $246.81M | +3,365,541 | 0.02% |
| Bank Of America Corp /De/ | 9,346,742 | 4.47% | $222.55M | +6,131,075 | 0.01% |
| Vanguard Capital Management LLC | 8,144,247 | 3.89% | $193.91M | +170,584 | 0.00% |
| William Blair Investment Management, LLC | 7,761,403 | 3.71% | $184.80M | +2,546,789 | 0.56% |
| State Street Corp | 7,297,494 | 3.49% | $173.75M | +3,003,800 | 0.01% |
| Hood River Capital Management LLC | 6,184,526 | 2.96% | $147.25M | +130,049 | 1.07% |
| Price T Rowe Associates Inc /Md/ | 4,939,145 | 2.36% | $117.60M | −802,161 | 0.01% |
| Geode Capital Management, LLC | 4,845,510 | 2.32% | $115.39M | +434,170 | 0.01% |
| Capital Research Global Investors | 4,399,329 | 2.10% | $104.75M | +805,753 | 0.01% |
| Goldman Sachs Group Inc | 4,013,339 | 1.92% | $95.56M | +3,001,689 | 0.01% |
| Capital World Investors | 3,910,131 | 1.87% | $93.10M | +1,244,073 | 0.01% |
| Danica Pension, Livsforsikringsaktieselskab | 3,687,259 | 1.76% | $87.79M | +1,183,682 | 1.40% |
| Bank of New York Mellon Corp | 3,657,160 | 1.75% | $87.08M | +344,050 | 0.01% |
| Allspring Global Investments Holdings, LLC | 3,053,525 | 1.46% | $73.32M | +595,125 | 0.11% |
| Next Century Growth Investors LLC | 2,537,598 | 1.21% | $60.42M | +275,522 | 3.20% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 323 | 222M | 100.0% | 80 / 142 | 81 / 46 | 53M | 32M |
| Q1 2026 | 293 | 202M | 96.4% | 77 / 111 | 75 / 42 | 53M | 28M |
| Q4 2025 | 263 | 193M | 92.4% | 55 / 128 | 63 / 25 | 38M | 28M |
| Q3 2025 | 236 | 184M | 88.1% | 55 / 97 | 70 / 35 | 36M | 40M |
| Q2 2025 | 217 | 188M | 90.1% | 53 / 102 | 50 / 41 | 44M | 38M |
| Q1 2025 | 207 | 183M | 87.4% | 53 / 95 | 42 / 17 | 24M | 17M |
| Q4 2024 | 172 | 176M | 84.3% | 47 / 66 | 38 / 11 | 30M | 21M |
| Q3 2024 | 137 | 167M | 79.8% | 30 / 45 | 42 / 10 | 19M | 12M |
| Q2 2024 | 118 | 168M | 80.3% | 19 / 52 | 34 / 30 | 12M | 9M |
| Q1 2024 | 130 | 165M | 78.8% | 28 / 36 | 45 / 19 | 14M | 13M |
| Q4 2023 | 121 | 164M | 78.2% | 10 / 41 | 48 / 20 | 6M | 4M |
| Q3 2023 | 131 | 162M | 77.3% | 18 / 50 | 43 / 27 | 5M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
364 funds held ALHC in Q2 2026, 31% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of ALHC | Value | % of fund | As of |
|---|---|---|---|---|---|
| SMALLCAP World Fund Inc | 7,393,726 | 3.53% | $176.04M | 0.19% | Jun 30, 2026 |
| Vanguard Health Care Fund | 6,928,007 | 3.31% | $102.88M | 0.27% | Jul 31, 2026 |
| Vanguard Total Stock Market Index Fund | 5,893,898 | 2.82% | $140.33M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 4,587,528 | 2.19% | $109.23M | 0.13% | Jun 30, 2026 |
| iShares Core S&P Small-Cap ETF | 4,555,244 | 2.18% | $108.46M | 0.10% | Jun 30, 2026 |
| Invesco Discovery Fund | 4,299,086 | 2.05% | $65.86M | 0.84% | May 31, 2026 |
| Vanguard Small-Cap Index Fund | 4,268,708 | 2.04% | $101.64M | 0.05% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Stock Fund, Inc. | 4,164,540 | 1.99% | $99.16M | 1.07% | Jun 30, 2026 |
| Hood River Small-Cap Growth Fund | 4,079,124 | 1.95% | $97.12M | 1.46% | Jun 30, 2026 |
| Select Health Care Portfolio | 2,600,000 | 1.24% | $39.83M | 0.69% | May 31, 2026 |
| Vanguard Small-Cap Growth Index Fund | 2,457,966 | 1.17% | $58.52M | 0.12% | Jun 30, 2026 |
| T. Rowe Price Institutional Small-Cap Stock Fund | 2,270,563 | 1.09% | $54.06M | 1.08% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 2,232,675 | 1.07% | $33.16M | 0.10% | Jul 31, 2026 |
| T. Rowe Price New Horizons Fund, Inc. | 2,190,075 | 1.05% | $52.15M | 0.35% | Jun 30, 2026 |
| T. Rowe Price Small-Cap Value Fund, Inc. | 2,016,767 | 0.96% | $48.02M | 0.45% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Joseph S. Konowiecki | EVP, Corporate Affairs, Director | 1,075,375 | 0.51% | Nov 12, 2026 |
| John E. Kao | Chief Executive Officer, Director | 1,814,239 | 0.87% | Sep 16, 2026 |
| Hyong Kim | Chief Medical Officer | 299,271 | 0.14% | Oct 7, 2026 |
| Dawn Christine Maroney | President | 794,606 | 0.38% | Sep 11, 2026 |
| Shane J. Hochradel | Chief Operations Officer | 87,719 | 0.04% | Jul 2, 2026 |
| Mark D. Kent | President - MSO | 102,567 | 0.05% | Jun 9, 2026 |
| James M. Head | Chief Financial Officer | 173,495 | 0.08% | Apr 8, 2026 |
| Christopher J. Joyce | Chief Legal and Admin. Officer | 305,451 | 0.15% | Apr 1, 2026 |
| Sebastian Burzacchi | COO - Mgmt Services Org | 258,630 | 0.12% | Mar 19, 2026 |
| Robert L. Scavo | Chief Information Officer | 487,685 | 0.23% | Mar 19, 2026 |
| Andreas P. Wagner | Chief Human Resources Officer | 148,628 | 0.07% | Mar 19, 2026 |
| Adnan R. Mansour | Chief Digital Officer | 48,456 | 0.02% | Mar 17, 2026 |
| Hakan Kardes | Chief Experience Officer | 678,987 | 0.32% | Mar 28, 2025 |
| Robert Thomas Freeman | Chief Financial Officer | 1,557,348 | 0.74% | Mar 28, 2025 |
| Mark B. McClellan | Director | 370,531 | 0.18% | Mar 17, 2026 |
| Yon Jorden | Director | 105,830 | 0.05% | Mar 17, 2026 |
| Nicholas Robbert Vorhoff | Director | 173,408 | 0.08% | Mar 17, 2026 |
| Jacqueline B. Kosecoff | Director | 303,963 | 0.15% | Mar 17, 2026 |
| Margaret M. McCarthy | Director | 144,441 | 0.07% | Mar 17, 2026 |
| Jody L. Bilney | Director | 129,267 | 0.06% | Mar 17, 2026 |
| David C. Hodgson | Director | 173,408 | 0.08% | Mar 17, 2026 |
| GAP Coinvestments V, LLC | 10% owner | 61,302,175 | 29.29% | Dec 12, 2025 |
| Gmbh & Co Kg Gapco | 10% owner | 78,511,411 | 37.52% | Dec 12, 2025 |
| General Atlantic, L.P. | 10% owner | 76,328,615 | 36.47% | Dec 12, 2025 |
| GAP Coinvestments CDA, L.P. | 10% owner | 30,842,175 | 14.74% | Dec 12, 2025 |
| Gap Coinvestments Iv, Llc | 10% owner | – | – | Dec 12, 2025 |
| General Atlantic Genpar, L.P. | 10% owner | 13,476,585 | 6.44% | Dec 12, 2025 |
| Gap Coinvestments Iii, Llc | 10% owner | – | – | Dec 12, 2025 |
| General Atlantic Partners 95, L.P. | 10% owner | 24,596,079 | 11.75% | Dec 12, 2025 |
| General Atlantic (SPV) GP, LLC | 10% owner | 67,949,317 | 32.47% | Dec 12, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Nov 10, 2026 | Sale | −4,930 | $7.20 | $35.50K | 1,075,375 |
| Hyong Kim Chief Medical Officer | Oct 6, 2026 | Sale | −32,479 | $8.30 | $269.58K | 299,271 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Sep 17, 2026 | Sale | −23,511 | $8.61 | $202.43K | 1,080,305 |
| John E. Kao Chief Executive Officer, Director | Sep 14, 2026 | Sale(10b5-1 plan) | −27,400 | $13.00 | $356.20K | 590,766 |
| Dawn Christine Maroney President | Sep 11, 2026 | Sale | −122,707 | $12.68 | $1.56M | 794,606 |
| John E. Kao Chief Executive Officer, Director | Sep 11, 2026 | Sale(10b5-1 plan) | −385,270 | $12.68 | $4.89M | 1,223,473 |
| John E. Kao Chief Executive Officer, Director | Sep 10, 2026 | Sale(10b5-1 plan) | −172,600 | $12.96 | $2.24M | 618,166 |
| Dawn Christine Maroney President | Aug 14, 2026 | Sale(10b5-1 plan) | −5,000 | $14.00 | $70.00K | 917,313 |
| John E. Kao Chief Executive Officer, Director | Aug 10, 2026 | Sale(10b5-1 plan) | −298,000 | $13.88 | $4.14M | 790,766 |
| Dawn Christine Maroney President | Jul 15, 2026 | Option exercise | +152,068 | $9.06 | $1.38M | 1,099,381 |
| Dawn Christine Maroney President | Jul 15, 2026 | Sale(10b5-1 plan) | −177,068 | $20.83 | $3.69M | 922,313 |
| John E. Kao Chief Executive Officer, Director | Jul 10, 2026 | Sale(10b5-1 plan) | −18,356 | $20.65 | $379.05K | 1,088,766 |
| John E. Kao Chief Executive Officer, Director | Jul 10, 2026 | Sale(10b5-1 plan) | −279,644 | $19.81 | $5.54M | 1,107,122 |
| Shane J. Hochradel Chief Operations Officer | Jul 1, 2026 | Award | +87,719 | – | – | 87,719 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jul 1, 2026 | Sale(10b5-1 plan) | −25,000 | $24.00 | $600.00K | 1,103,816 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jun 26, 2026 | Sale(10b5-1 plan) | −25,000 | $23.00 | $575.00K | 1,128,816 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jun 18, 2026 | Sale(10b5-1 plan) | −25,000 | $22.00 | $550.00K | 1,153,816 |
| Dawn Christine Maroney President | Jun 15, 2026 | Sale(10b5-1 plan) | −30,000 | $19.55 | $586.50K | 947,313 |
| Hyong Kim Chief Medical Officer | Jun 12, 2026 | Sale(10b5-1 plan) | −35,951 | $19.86 | $713.99K | 331,750 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jun 11, 2026 | Sale(10b5-1 plan) | −25,000 | $21.00 | $525.00K | 1,178,816 |
| John E. Kao Chief Executive Officer, Director | Jun 10, 2026 | Sale(10b5-1 plan) | −223,064 | $20.60 | $4.60M | 1,386,766 |
| John E. Kao Chief Executive Officer, Director | Jun 10, 2026 | Sale(10b5-1 plan) | −74,936 | $19.65 | $1.47M | 1,609,830 |
| Mark D. Kent President - MSO | Jun 3, 2026 | Award | +87,719 | – | – | 102,567 |
| Joseph S. Konowiecki EVP, Corporate Affairs, Director | Jun 3, 2026 | Award | +122,807 | – | – | 1,203,816 |
| Mark D. Kent President - MSO | Jun 2, 2026 | Buy | +14,848 | $13.31 | $197.63K | 14,848 |
| Dawn Christine Maroney President | May 18, 2026 | Gift | −20,000 | – | – | 977,313 |
| Dawn Christine Maroney President | May 15, 2026 | Sale(10b5-1 plan) | −30,000 | $16.09 | $482.70K | 998,813 |
| Dawn Christine Maroney President | May 15, 2026 | Gift | −1,500 | – | – | 997,313 |
| John E. Kao Chief Executive Officer, Director | May 11, 2026 | Sale(10b5-1 plan) | −17,107 | $17.54 | $300.06K | 1,508,641 |
| John E. Kao Chief Executive Officer, Director | May 11, 2026 | Sale(10b5-1 plan) | −280,893 | $16.85 | $4.73M | 1,525,748 |
| Dawn Christine Maroney President | Apr 15, 2026 | Sale(10b5-1 plan) | −30,000 | $20.87 | $626.10K | 1,028,813 |
| John E. Kao Chief Executive Officer, Director | Apr 13, 2026 | Sale(10b5-1 plan) | −82,299 | $20.80 | $1.71M | 1,806,641 |
| John E. Kao Chief Executive Officer, Director | Apr 10, 2026 | Sale(10b5-1 plan) | −13,801 | $21.38 | $295.07K | 1,888,940 |
| John E. Kao Chief Executive Officer, Director | Apr 10, 2026 | Sale(10b5-1 plan) | −201,900 | $20.58 | $4.16M | 1,902,741 |
| James M. Head Chief Financial Officer | Apr 7, 2026 | Sale | −11,100 | $21.08 | $233.99K | 173,495 |
| John E. Kao Chief Executive Officer, Director | Apr 7, 2026 | Sale(10b5-1 plan) | −132,241 | $20.67 | $2.73M | 2,222,400 |
| John E. Kao Chief Executive Officer, Director | Apr 7, 2026 | Sale(10b5-1 plan) | −117,759 | $21.40 | $2.52M | 2,104,641 |
| Christopher J. Joyce Chief Legal and Admin. Officer | Apr 1, 2026 | Sale(10b5-1 plan) | −18,013 | $17.79 | $320.45K | 305,451 |
| John E. Kao Chief Executive Officer, Director | Mar 23, 2026 | Sale(10b5-1 plan) | −118,000 | $17.48 | $2.06M | 2,354,641 |
| Andreas P. Wagner Chief Human Resources Officer | Mar 19, 2026 | Sale(10b5-1 plan) | −11,602 | $18.22 | $211.39K | 148,628 |
| Christopher J. Joyce Chief Legal and Admin. Officer | Mar 18, 2026 | Sale | −25,125 | $17.84 | $448.23K | 323,464 |
| Dawn Christine Maroney President | Mar 18, 2026 | Sale | −36,749 | $17.84 | $655.60K | 1,058,813 |
| Sebastian Burzacchi COO - Mgmt Services Org | Mar 18, 2026 | Sale | −15,361 | $17.84 | $274.04K | 258,630 |
| Hyong Kim Chief Medical Officer | Mar 18, 2026 | Sale | −18,404 | $17.84 | $328.33K | 367,701 |
| Andreas P. Wagner Chief Human Resources Officer | Mar 18, 2026 | Sale(10b5-1 plan) | −12,000 | $17.84 | $214.08K | 160,230 |
| John E. Kao Chief Executive Officer, Director | Mar 18, 2026 | Sale | −73,046 | $17.84 | $1.30M | 1,784,868 |
| Robert L. Scavo Chief Information Officer | Mar 18, 2026 | Sale | −11,285 | $17.84 | $201.32K | 487,685 |
| Dawn Christine Maroney President | Mar 16, 2026 | Sale(10b5-1 plan) | −30,000 | $17.48 | $524.40K | 1,095,562 |
| Yon Jorden Director | Mar 13, 2026 | Award | +13,096 | – | – | 105,830 |
| James M. Head Chief Financial Officer | Mar 13, 2026 | Award | +103,002 | – | – | 184,595 |
| Christopher J. Joyce Chief Legal and Admin. Officer | Mar 13, 2026 | Award | +51,501 | – | – | 348,589 |
| David C. Hodgson Director | Mar 13, 2026 | Award | +18,982 | – | – | 173,408 |
| Joseph S. Konowiecki Director | Mar 13, 2026 | Award | +24,868 | – | – | 1,081,009 |
| Hyong Kim Chief Medical Officer | Mar 13, 2026 | Award | +52,972 | – | – | 386,105 |
| John E. Kao Chief Executive Officer, Director | Mar 13, 2026 | Award | +338,434 | – | – | 1,857,914 |
| Jody L. Bilney Director | Mar 13, 2026 | Award | +16,039 | – | – | 129,267 |
| Andreas P. Wagner Chief Human Resources Officer | Mar 13, 2026 | Award | +23,543 | – | – | 172,230 |
| Adnan R. Mansour Chief Digital Officer | Mar 13, 2026 | Award | +25,015 | – | – | 48,456 |
| Margaret M. McCarthy Director | Mar 13, 2026 | Award | +14,273 | – | – | 144,441 |
| Mark B. McClellan Director | Mar 13, 2026 | Award | +13,096 | – | – | 370,531 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Alignment Healthcare's stock actually held short. Settlement fails (shares not delivered on time) peaked at 615,856 shares on Sep 25, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Joseph S. Konowiecki Chairman / EVP, Corporate Affairs | Nov 9, 2026 | 5,500 | $39.99K | Nov 10, 2026 | The Common Stock was acquired through the vesting of restricted stock units granted on 11/07/2022 under the Issuer's 2021 Equity Incentive Plan |
| Hyong Kim Chief Medical Officer | Oct 5, 2026 | 36,000 | $305.28K | Oct 6, 2026 | The Common Stock was acquired through the vesting of restricted stock units granted on 10/04/2023 under the Issuer's 2021 Equity Incentive Plan |
| Joseph S. Konowiecki Director / EVP, Corporate Affairs | Sep 16, 2026 | 26,000 | $226.46K | Sep 17, 2026 | The Common Stock was acquired through the vesting of restricted stock units granted on 09/14/2023 under the Issuer's 2021 Equity Incentive Plan |
| Jek Trust U/A Dtd 02/08/2021 Director, Officer | Sep 10, 2026 | 500,000 | $6.52M | Sep 10, 2026 | Shares Issued Pre-IPO in exchange for Partnership Units |
| Dawn Christine Maroney President | Sep 9, 2026 | 130,000 | $1.70M | Sep 10, 2026 | The Common Stock was acquired through the vesting of restricted stock units granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan |
| John E. Kao Chief Executive Officer / Director | Sep 9, 2026 | 405,000 | $5.29M | Sep 10, 2026 | The Common Stock was acquired through the vesting of restricted stock units granted on 09/12/2022 under the Issuer's 2021 Equity Incentive Plan |
| Dawn Christine Maroney Officer | Aug 14, 2026 | 5,000 | $67.30K | Aug 14, 2026 | RSU/PSU |
| Dawn Christine Maroney Officer | Jul 15, 2026 | 177,068 | $3.75M | Jul 15, 2026 | Exercise of Stock Options |
| Jek Trust U/A Dtd 02/08/2021 Director, Officer | Jul 10, 2026 | 596,000 | $12.53M | Jul 10, 2026 | Shares Issued Pre-IPO in exchange for Partnership Units |
| Joseph S. Konowiecki Director | Jul 1, 2026 | 25,000 | $600.00K | Jul 1, 2026 | Stock Bonus |
| Joseph S. Konowiecki Director | Jun 26, 2026 | 25,000 | $575.00K | Jun 26, 2026 | Stock Bonus |
| Joseph S. Konowiecki Director | Jun 18, 2026 | 25,000 | $550.00K | Jun 18, 2026 | Stock Bonus |
| Sebastian Burzacchi Officer | Jun 12, 2026 | 1,142 | $23.11K | Jun 12, 2026 | Restricted Stock Units |
| Hyong Kim Officer | Jun 12, 2026 | 35,951 | $727.65K | Jun 12, 2026 | Restricted Stock Units |
| Joseph S. Konowiecki Director | Jun 11, 2026 | 25,000 | $525.00K | Jun 11, 2026 | Stock Bonus |
See a number that looks wrong?